Danaher returns bioprocessing to growth. We’re raising our rating back to a buy

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 

Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.

Source link

Share with your friends!

Leave a Reply

Your email address will not be published. Required fields are marked *

Get The Best Financial Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.